![](https://in2pharma.com/wp-content/uploads/2020/07/coronavirus-4932607_1920-300x200.jpg)
Belgium
These measures and their extension until 28th of July 2020, should lead to solutions and alternatives for all drugs needed for the treatment of COVID-19 patients in Belgium now and in the near future.
On 1 April 2020, the FAMHP took steps regarding a range of medicinal products in order to avoid any shortage. These measures have now been extended to 28th August 2020 according to the new decision.